Tuesday, July 6, 2021

Voxtur Bio unveils pan-India plan to expand In-vitro diagnostics (IVD) kit distribution network – Express Healthcare



Read Article

The ramped-up manufacturing facility to produce 12 million diagnostics testing solutions a month

Mumbai-based diagnostics company Voxtur Bio has rolled out a pan-India plan to expand its In-vitro Diagnostics (IVD) kit distribution network. As a part of the strategy, the company will onboard more than 100 marketing professionals across key metros and cities in India to strengthen its order procurement and supply capability.

To ramp up its manufacturing strength, the company has set up a 40,000 sq. ft. state-of-the-art manufacturing facility in Vasai on the outskirts of Mumbai with a production capacity of 12 million tests per month.

As the IVD market in India is growing at a rapid pace, Voxtur Bio aims to capture a larger market share with its affordable world-class IVD test kits and reagents.

In line with the government’s ‘Make in India’ mission, the company is bolstering its manufacturing and distribution wherewithal to reduce dependence on imports from countries like China.

Set up in 2015 by Dr Veeraal Gandhi, Voxtur Bio produces high-quality FDA-compliant rapid testing kits, blood grouping sera, latex reagents, enzyme-linked immunosorbent assay (ELISA) testing kits, blood collection tubes and laboratory plastic consumables. Its manufacturing capability draws strength from in-house research and development competency and advanced technology integration. The company is into the OEM, domestic distribution, exports and government business.

“The IVD market is growing at a faster clip because of the growth of lifestyle ailments and heightened awareness of minimally-invasive and non-invasive diagnostic techniques. However, the supply from multi-national companies and imports is catering to the IVD demand of only the metro and tier-I cities while a vast part of the market still remains underserved and underleveraged. With our enhanced manufacturing bandwidth and distribution network, we aim to meet the growing demand with our affordable world-class IVD solutions. Domestically-manufactured IVD solutions go a long way in reducing the healthcare cost of the country,” said Dr Veeraal Gandhi, Chairman and Managing Director, Voxtur Bio.



Source link

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...